Deutsche Bank Maintains a 'Hold' on Amgen (AMGN); Legacy Business and Prolia Show Signs of Life
Tweet Send to a FriendGet Alerts AMGN Hot Sheet
Price: $104.24 +2.02%
Rating Summary:
12 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
12 Buy, 15 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade AMGN Now!
Deutsche Bank maintains a 'Hold' on Amgen (NASDAQ: AMGN) price target of $84.00 (from $72.00).
Analyst, Robyn Karnauskas, said, "In terms of legacy products, Epogen, Aranesp, Neupogen, Enbrel & Sensipar all beat expectations. Epogen ($525M vs. $447M consensus) & Enbrel ($1,058M vs. $962M consensus) were especially strong. The Dmab franchise also posted a solid Q2 driven by a Prolia beat by $20M ($120M vs. $100M consensus). This all led to beat on product sales beat by $200M & EPS by $0.30 ($1.83 vs. $1.53)...Pipeline is emerging – We like AMG785, AMG145 & brodalumab – All upside."
Raising FY12 EPS estimates and revenues.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $79.30 yesterday, with a 52 week range of $47.66-$80.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Robyn Karnauskas, said, "In terms of legacy products, Epogen, Aranesp, Neupogen, Enbrel & Sensipar all beat expectations. Epogen ($525M vs. $447M consensus) & Enbrel ($1,058M vs. $962M consensus) were especially strong. The Dmab franchise also posted a solid Q2 driven by a Prolia beat by $20M ($120M vs. $100M consensus). This all led to beat on product sales beat by $200M & EPS by $0.30 ($1.83 vs. $1.53)...Pipeline is emerging – We like AMG785, AMG145 & brodalumab – All upside."
Raising FY12 EPS estimates and revenues.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $79.30 yesterday, with a 52 week range of $47.66-$80.25.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- First Time Cruisers Pass on Carnival (CCL); Wells Fargo Cuts to Market Perform
- Jefferies Bumps PT/Est. on AO Smith (AOS)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Deutsche Bank
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
